Saller D N, Nagey D A, Pupkin M J, Crenshaw M C
Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore.
J Perinatol. 1990 Jun;10(2):125-8.
Fifteen patients were identified in a retrospective analysis of one institution's experience with the use of tocolysis in selected patients with an admission diagnosis of placenta previa or abruptio placentae. There were no fetal deaths after admission, and the two neonatal deaths were related to prematurity. Eight of the 15 patients receiving tocolysis had their pregnancies prolonged by 2 weeks or more, and there were no fetal or neonatal deaths in this group. Both neonatal deaths occurred in patients who underwent tocolysis but who gave birth within 1 day of admission. These data suggest the safety of tocolysis in preterm patients with the diagnosis of placenta previa or abruption who are bleeding. A prospective, randomized trial is required to evaluate whether tocolysis is superior to expectant management or to immediate delivery. The clinical difficulty in differentiating between these two diagnoses, despite liberal use of ultrasonography, is discussed.
在对某机构对选定的入院诊断为前置胎盘或胎盘早剥患者使用宫缩抑制剂的经验进行回顾性分析时,确定了15例患者。入院后无胎儿死亡,2例新生儿死亡与早产有关。15例接受宫缩抑制剂治疗的患者中有8例妊娠延长了2周或更长时间,该组无胎儿或新生儿死亡。2例新生儿死亡均发生在接受宫缩抑制剂治疗但入院后1天内分娩的患者中。这些数据表明,宫缩抑制剂对诊断为前置胎盘或胎盘早剥且有出血的早产患者是安全的。需要进行一项前瞻性随机试验,以评估宫缩抑制剂是否优于期待治疗或立即分娩。文中讨论了尽管广泛使用超声检查,但区分这两种诊断的临床困难。